Publikationen 1996-
2021
- Activation of interferon regulatory factor 3 by raplication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses. (pdf, 2,0 M)
Riederer S., Fux R., Lehmann M.H., Volz A., Sutter G., Rojas J.J.
Mol Ther: Oncolytics 2021 Sep 24; 22:399-409. doi: 10.1016/j.omto.2021.06.001
2017
- A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells. (pdf, 1,89 MB)
Link E.K., Brandmüller C., Suezer Y., Ameres S., Volz A., Moosmann A., Sutter G., Lehmann M.H.
Vaccine, 35(38), 5131-5139 (2017) - Ectromelia virus accumulates less double-stranded RNA compared to vaccinia virus in BS-C-1 cells. (pdf, 1,56 MB)
Frey T.R., Lehmann H.M., Ryan C.M., Pizzorno, M.C., Sutter G., Hersperger A.R.
Virology 509, 98-111 (2017)
2016
- CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection. (pdf, 1,26 MB)
Lehmann M.H., Torres-Dominquez L.E., Price P.J.R., Brandmüller C., Kirschning C.J., Sutter G.
J. Leukoc. Biol., 99(6), 1057-1964 (2016)
2015
- Modified vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage. (pdf, 992 KB)
Lehmann M.H., Price P.J.R., Brandmüller C., Sutter G.
Virology J., 12, 21 (2015) - Complement component C5 recruits neutrophils in the absence of C3 during respiratory infection with modified vaccinia virus Ankara. (pdf, 389 KB)
Price P.J.R., Banki Z., Scheideler A., Stoiber H., Verschoor A., Sutter G., Lehmann M.H.
J. Immunol., 194(3), 1164-1168 (2015)
- Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influeza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial. (pdf, 276 KB)
Kreijtz J.H.C.M., Goeijenbier M., Moesker F.M., Dries L. van den, Goeijenbier S., Gruyter H.L.M. De, Lehmann M.H., Mutsert G. de, Vijver D.A.M.C. van de, Volz A., Fouchier R.A.M., Gorp E.C.M. van, Rimmelzwaan G.F., Sutter G., Osterhaus A.D.M.E.
Lancet Infect. Dis., 14(12), 1196-1207 (2014)
- Chemokine (C-C motif) receptor 1 (CCR1) is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara. (pdf, 2,96 MB)
Price P.J., Luckow B., Torres-Dominquez L.E., Brandmüller C., Zorn J., Kirschning C.J., Sutter G., Lehmann M.H.
J. Virol., 88(18), 10840-10850 (2014)
2013
- Modified vaccinia virus Ankara: Innate immune activation and induction of cellular signalling. (pdf, 257 KB)
Price P.J.R., Torres-Dominquez L.E., Brandmüller C., Sutter, G., Lehmann M.H.
Vaccine, 31(39), 4231-4234 (2013)
- Easy and efficient protocols for working with recombinant vaccinia virus MVA. (online-abstract)
Kremer M., Volz A., Kreijtz J.H., Fux R., Lehmann M.H., Sutter G.
Methods Mol. Biol., 890, 59-92 (2012)
- Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox. (pdf, 2,1 MB)
Kremer M.*, Suezer Y.*, Volz A.*, Frenz T., Majzoub M., Hanschmann K.-M., Lehmann M.H., Kalinke U.,
Sutter G.
PLoS Pathogens, 8(3), e1002557 (2012); *equal contribution
- HIV-1 Nef increases astrocyte sensitivity towards exogenous hydrogen peroxide. (pdf, 628 KB)
Masanetz S., Lehmann M.,
Virol. J., 8, 35 (2011)
- Modified vaccinia virus Ankara (MVA) based vaccines - immunostimulatory and protective capacity.
(online-abstract)
Lehmann M.H., Kremer M., Suezer Y., Sutter G.
In: Biomedical and Life Sciences. The Challenge of Highly Pathogenic Microorganisms. Springer Verlag, (2010)
- Modified vaccinia virus Ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression. (pdf, 3,1 M)
Lehmann M.H., Kastenmuller W., Kandemir J.D., Brandt F., Suezer Y., Sutter G.
J. Virol., 83(6), 2540-2552 (2009)
- Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha(4) expression. (pdf, 9 MB)
Weinländer K., Naschberger E., Lehmann M.H., Tripal P., Paster W., Stockinger H., Hohenadl C., Sturzl M.
Faseb Journal, 22(12), 4168-4178 (2008)
- HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner. (pdf, 11 MB)
Lehmann M.H., Masanetz S., Kramer S., Erfle V.
Journal of Cell Science, 119(21), 4520-4530 (2006) - Extracellular HIV-1 Nef increases migration of monocytes. (online-abstract)
Lehmann M.H., Walter S., Ylisastigui L., Striebel F., Ovod V., Geyer M., Gluckman J.C., Erfle V.
Experimental Cell Research, 312(18), 3659-3668 (2006) - Chemotactic activity of serum obtained from patients with idiopathic dilated cardiomyopathy. (online-abstract)Sigusch H.H., Lehmann M.H., Reinhardt D., Henke A., Zell R., Leipner C., Figulla H.R.
Pharmazie, 61(8), 706-709 (2006)
- Role of viral factor E3L in modified vaccinia virus Ankara infection of human HeLa cells: Regulation of the virus life cycle and identification of differentially expressed host genes. (pdf, 534 K)
Ludwig H., Mages J., Staib C., Lehmann M.H., Lang R., Sutter G.
J. Virol., 79(4), 2584-2596 (2005)
- Pseudogene-free amplification of human GAPDH cDNA.
Lehmann M.H., Weber J., Gastmann O., Sigusch H.H.
Biotechniques, 33(4), 766, 769-770 (2002) - Identification and validation of selective upregulation of ventricular myosin light chain type 2 mRNA in idiopathic dilated cardiomyopathy. (pdf, 1115 K)
Haase D., Lehmann M.H, Korner M.M., Korfer R., Sigusch H.H., Figulla H.R.
European Journal of Heart Failure, 4(1), 23-31 (2002)
- Constitutive expression of MCP-1 and RANTES in the human histiocytic lymphoma cell line U-937.
Lehmann M.H., Schreiber S., Vogelsang H., Sigusch H.H.
Immunology Letters, 76(2), 111-113 (2001)
- Angiotensin II type 1 receptor gene polymorphism is associated with the severity but not prevalence of coronary artery disease. (pdf, 47 K)
Surber R., Sigusch H.H., Lehmann M.H., Reinhardt D., Hoffmann A., Figulla H.R.
Clinical Genetics, 58(3), 237-238 (2000) - Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: Correlation to myocardial inflammatory activity. (online-abstract)
Sigusch H.H., Lehmann M.H., Schnittler U., Reinhardt D., Figulla H.R.
Cytokine, 12(8), 1261-1266 (2000) - Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. (online-abstract)
Sigusch H.H., Surber R., Lehmann M.H., Surber S., Weber J., Henke A., Reinhardt D., Hoffmann A., Figulla H.R.
Scandinavian Journal of Clinical & Laboratory Investigation, 60(3), 229-235 (2000) - Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population. (online-abstract)
Farker K., Lehmann M.H., Kastner R., Weber J., Janitzky V., Schubert J., Hoffmann A.
International Journal of Clinical Pharmacology and Therapeutics, 38(1), 30-34 (2000)
- Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. (online-abstract)
Platzer C., Fritsch E., Elsner T., Lehmann M.H., Volk H.D., Prosch S.
European Journal of Immunology, 29(10), 3098-3104 (1999)
- Electroporation induced gene expression - a case study on interleukin-10. (online abstract)
Lehmann M.H., Berg H.
Bioelectrochemistry and Bioenergetics, 47(1), 3-10 (1998) - Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy. (online-abstract)
Lehmann M.H., Kuhnert H., Muller S., Sigusch H.H.
Cytokine, 10(10), 739-746 (1998) - Recombinant human granulocyte-macrophage colony-stimulating factor triggers interleukin-10 expression in the monocytic cell line U937. (online-abstract)
Lehmann M.H.
Molecular Immunology, 35(8), 479-485 (1998) - Interleukin-10 expression is induced by increase of intracellular calcium levels in the monocytic cell line U937 . (online-abstract)
Lehmann M.H., Berg H.
Pflugers Archiv-European Journal of Physiology, 435(6), 868-870 (1998) - CYP2E1 genotyping in renal cell urothelial cancer patients in comparison with control populations.
(online-abstract)
Farker K., Lehmann M.H., Kastner R., Hoffmann A., Janitzky V., Schubert J., Matz U., Hofmann W.
International Journal of Clinical Pharmacology and Therapeutics, 36(9), 463-468 (1998) - Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. (online-abstract)
Farker K., Lehmann M.H., Oelschlagel B., Haerting J., Hoffmann A., Janitzky V., Schubert J.Experimental and Toxicologic Pathology, 50(4-6), 425-431 (1998)
- Electroporation stimulates interleukin 10 production in human monocytic cell lines THP-1 and U937.
Lehmann M.H., Hoffken K., Berg H.
Bioelectrochemistry and Bioenergetics, 41(2), 227-229 (1996)